대한약학회:학술대회논문집 (Proceedings of the PSK Conference)
- 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
- /
- Pages.249.1-249.1
- /
- 2002
Attenuation of monocrotaline-induced pulmonary hypertension with DA-8159, a potent PDE 5 inhibitor
- Ahn, Gook-Jun (Dong-A Pharmaceutical Research Institute) ;
- Kang, Kyung-Koo (Dong-A Pharmaceutical Research Institute) ;
- Sohn, Yong-Sung (Dong-A Pharmaceutical Research Institute) ;
- Choi, Seu-Min (Dong-A Pharmaceutical Research Institute) ;
- Kim, Ju-Mi (Dong-A Pharmaceutical Research Institute) ;
- Kim, Dong-Hwan (Dong-A Pharmaceutical Research Institute) ;
-
Ahn, Byoung-Ok
(Dong-A Pharmaceutical Research Institute)
;
- Kim, Won-Bae (Dong-A Pharmaceutical Research Institute)
- 발행 : 2002.10.01
초록
This study was carried out to demonstrate the effects of oral administration of DA-8159. a selective phosphodiesterase 5 inhibitor. on development of pulmonary hypertension induced by monocrotaline (MCT). MCT-treated rats(60mg/kg) were divided into three groups and orally administered vehicle, 1 mg/kg or 5 mg/kgg of DA-8159 twice a day for 3 weeks. Increased right ventricular weights, medial wall thickening in pulmonary arteries. myocardial fibrosis, decrease of plasma cyclic guanosine monophosphate (cGMP) level and body weight gains were shown in MCT group. (omitted)
키워드